The Cardiac Neurodevelopmental Clinic (CNC) at CHOC’s Heart Institute is helping patients like Grace make vast improvements with their neurodevelopment.
CHOC’s study published in the Pediatrics journal finds that though COVID-19 infections in newborns are rare, they may cause severe disease.
The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
New CHOC study integrating mental health into primary care seeks patients to receive cognitive therapy and/or medication.
Dr. Raina Paul is making strides in quality-improvement science to better pediatric sepsis at CHOC’s emergency department.